I’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the assets that could help you create wealth from these events, even as so many others watch their portfolios destroyed.

Everything you need to know is here in my emergency broadcast.

Rajeev Modi Biography and Net Worth

Insider of Elanco Animal Health

Bobby Modi serves as Executive Vice President, U.S. Pet Health and Global Digital Transformation.

Bobby joined Elanco in March of 2022, after serving as Vice President and General Manager of Enhancers and Components at Conagra Brands from May 2021 to April 2022. At Congara Brands he was responsible for the company’s substantial grocery business, positioning it for profitable growth. Prior to that, he held numerous vice president roles at J.M. Smucker Co. from 2012 to 2021.

Bobby holds a bachelor’s degree in Chemical Engineering from the University of Cincinnati and a master’s degree in Marketing, Management Strategy and Finance from Northwestern’s Kellogg School of Management.

What is Rajeev A. Modi's net worth?: The estimated net worth of Rajeev A. Modi is at least $596,776.50 as of September 9th, 2022. Mr. Modi owns 41,157 shares of Elanco Animal Health stock worth more than $596,777 as of November 7th. This net worth evaluation does not reflect any other assets that Mr. Modi may own. Learn More about Rajeev A. Modi's net worth.
How do I contact Rajeev A. Modi?: The corporate mailing address for Mr. Modi and other Elanco Animal Health executives is 2500 INNOVATION WAY, GREENFIELD IN, 46140. Elanco Animal Health can also be reached via phone at (877) 352-6261 and via email at [email protected]. Learn More on Rajeev A. Modi's contact information.
Has Rajeev A. Modi been buying or selling shares of Elanco Animal Health?: Rajeev A. Modi has not been actively trading shares of Elanco Animal Health during the last quarter. Most recently, on Friday, September 9th, Rajeev A. Modi bought 6,700 shares of Elanco Animal Health stock. The stock was acquired at an average cost of $14.90 per share, with a total value of $99,830.00. Following the completion of the transaction, the insider now directly owns 41,157 shares of the company's stock, valued at $613,239.30. Learn More on Rajeev A. Modi's trading history.
Who are Elanco Animal Health's active insiders?: Elanco Animal Health's insider roster includes John Bilbrey (Director), Art Garcia (Director), Michael Harrington (Director), R. Hoover (Director), Rajeev Modi (Insider), Jeffrey Simmons (CEO), and Todd Young (Insider). Learn More on Elanco Animal Health's active insiders.
Are insiders buying or selling shares of Elanco Animal Health?: During the last year, Elanco Animal Health insiders bought shares 4 times. They purchased a total of 138,500 shares worth more than $1,930,475.00. The most recent insider tranaction occured on August, 22nd when Director Michael J Harrington bought 3,500 shares worth more than $51,975.00. Insiders at Elanco Animal Health own 0.6% of the company. Learn More about insider trades at Elanco Animal Health.
Information on this page was last updated on 8/22/2024.

Rajeev A. Modi Insider Trading History at Elanco Animal Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/9/2022	Buy	6,700	$14.90	$99,830.00	41,157

Rajeev A. Modi Buying and Selling Activity at Elanco Animal Health

Elanco Animal Health Company Overview

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Today's Range

Now: $14.50

$12.87

$14.75

50 Day Range

MA: $13.95

$12.38

$15.47

2 Week Range

Now: $14.50

$10.19

$18.80

Volume

9,244,498 shs

Average Volume

4,785,154 shs

Market Capitalization

$7.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.41

Urgent: This election is rigged

From Porter & Company | Ad